Skip to main content

Table 1 Characteristics of patients and tumor

From: Selective occlusion of the hepatic artery and portal vein improves liver hypertrophy for staged hepatectomy

Variable

Age (years)

Gender

Tumor diameter (mm)

AFP (ng/ml)

Child’s score

Planned procedure

Initial FLRV (ml), % of the SLV

Patient 1

23

Female

114

> 2000

5

Right trisectionectomy

421, 32.2%

Patient 2

42

Female

89

> 2000

5

Right hemihepatectomy

312, 28.7%

Patient 3

46

Male

123

582.7

5

Right hemihepatectomy

350, 25.0%

Patient 4

54

Male

155

557.9

6

Right hemihepatectomy

511, 37.9%

Patient 5

51

Male

130

1994.4

6

Left trisectionectomy

505, 35.8%

Patient 6

52

Female

95

227.5

6

Laparoscopic right hemihepatectomy

456, 37.7%

Patient 7

41

Male

205

> 2000

6

Right trisectionectomy

306, 27.3%

Patient 8

44

Male

130

1290.4

5

Right hemihepatectomy

385, 35.4%

Patient 9

42

Male

115

850.8

6

Laparoscopic right hemihepatectomy

358, 34.5%

  1. AFP the level of serum alpha-fetoprotein before operation, FLRV the volume of the future liver remnant, Initial FLRV, the FLRV before the first-stage operation, SLV standard liver volume